Evidence map›Paper›PMID 42404418›Full record

ArticleBasic and clinical neuroscience2025

Alpha-mangostin Ameliorates Apoptosis, Inflammation and Oxidative Stress in Cuprizone-induced Demyelination in C57BL/6 Mice.

Sara Banaeeyeh, Bibi Marjan Razavi, Hossein Hosseinzadeh

Abstract read
In one paragraph

Article in Basic and clinical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sara BanaeeyehDepartment of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID https://orcid.org/0000-0002-7252-2401
Bibi Marjan RazaviDepartment of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID https://orcid.org/0000-0002-7450-9286
Hossein HosseinzadehDepartment of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID https://orcid.org/0000-0002-3483-851X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Alpha-mangostin (α-MG), the most abundant xanthone found in Methods: Adult female C57BL/6 mice were fed a chow containing 0.4% (w/w) CZ for 5 weeks. The animals were randomly assigned to six groups: (1) control group receiving a standard diet; (2) CZ group receiving the CZ-containing diet; (3-5) CZ diet plus α-MG at doses of 20, 40, and 80 mg/kg/day administered via gavage; (6) standard diet plus α-MG at 80 mg/kg/day. At the end of the treatment period, levels of malondialdehyde (MDA), proapoptotic and anti-apoptotic markers (Bax, Bcl-2, cleaved caspase-3), and the inflammatory cytokine tumor necrosis factor-alpha (TNF-α) were measured in the CC. Results: Compared with the control group, CZ-treated mice exhibited significant weight loss (P<0.0001), elevated MDA levels (P<0.01), an increased Bax/Bcl-2 ratio, enhanced cleaved caspase-3 expression (P<0.0001), and increased TNF-α levels (P<0.001). Treatment with α-MG at 80 mg/kg significantly mitigated weight loss (P<0.01). Furthermore, α-MG at all tested doses (20, 40, and 80 mg/kg) significantly reduced MDA levels (P<0.01, P<0.001, and P<0.0001, respectively). Administration of α-MG at 80 mg/kg also significantly reduced the Bax/Bcl-2 ratio, cleaved caspase-3 expression (P<0.0001), and TNF-α levels (P<0.0001) compared with the CZ group. Conclusion: These findings demonstrate that α-MG attenuates the detrimental effects of CZ-induced demyelination in the CC by reducing oxidative stress, inflammation, and apoptosis.

Indexed as

Alpha-mangostin (α-MG)Corpus callosum (CC)CuprizoneMultiple sclerosis (MS)Neuroprotection

Identifiers

PMID42404418
PMCPMC13332360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.